Zipantola 40 mg želučanootporne tablete
Name | Zipantola 40 mg želučanootporne tablete |
---|---|
Marketing Authorisation Number | HR-H-834336223 |
Active Substance | pantoprazolnatrij seskvihidrat |
Composition | jedna želučanootporna tableta sadrži 40 mg pantoprazola u obliku pantoprazolnatrij seskvihidrata |
Pharmaceutical Form | želučanootporna tableta |
Packaging [MA Number for Packaging] | 14 tableta u blisteru, u kutiji [HR-H-834336223-01] 28 tableta u blisteru, u kutiji [HR-H-834336223-02] 14 tableta u perforiranom blisteru s jediničnim dozama, u kutiji. [HR-H-834336223-03] 28 tableta u perforiranom blisteru s jediničnim dozama, u kutiji. [HR-H-834336223-04] |
Manufacturer | Pliva Hrvatska d.o.o., Zagreb, Hrvatska Teva Pharma S.L.U., Zaragoza, Španjolska |
Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
Marketing Authorisation Date | 20.07.2015 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/14-02/465 |
Registration Number | 381-12-01/30-15-07 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | A02BC02 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |